<DOC>
	<DOCNO>NCT00816140</DOCNO>
	<brief_summary>Clarithromycin-based triple therapy contain proton-pump inhibitor ( PPI ) twice daily , amoxicillin 1g twice daily , clarithromycin 500 mg twice daily 7 day one standard firs-line therapy Helicobacter pylorus eradication . However , unsatisfactory eradication rate ( 80-85 % ) , Maastricht III guideline recommend extend treatment duration increase eradication rate . Recently , levofloxacin ( 500 mg qd ) -based triple therapy show achieve eradication rate 90 % first- second-line treatment H. pylorus eradication . Several study demonstrate high dose ( 750mg ) short-course ( 5 day ) levofloxacin effective well tolerate traditional dose ( 500mg ) course ( 10 day ) treatment mild-to-severe community acquire pneumonia . The high dose short-course therapy potential increase patient compliance reduce bacterial resistance fluoroquinolones . However , whether increase dosage levofloxacin 500mg 750 mg qd augment efficacy triple therapy eradication H. pylorus shorten duration therapy remain unknown . Although levofloxacin-based regimen presume effective , previous report point concern resistance fluoroquinolone antibiotic susceptible pump efflux bacteriae would increase among gut flora .</brief_summary>
	<brief_title>Levofloxacin Versus Clarithromycin Triple Therapy First-Line Treatment Helicobacter Pylori Eradication</brief_title>
	<detailed_description>Determination H. pylorus status Prior enrollment , status H. pylori infection determine ( 1 ) rapid urease test ( CLO test , Kimberly-Clark , USA ) antrum biopsy , ( 2 ) histological examination ( Giemsa stain ) antral body sample ( two antral mucosa two corpus mucosa ) , ( 3 ) culture . Positive two three test define positive H. pylorus infection . After-treatment H. pylorus status determine 13C-Urea Breath Test ( 13C-UBT ) 6 week completion treatment . Successful eradication H. pylorus define negative 13C-UBT result . Eradication Therapy Using computer-generated number sequence , patient meet inclusion criterion one exclusion criterion randomize receive one follow regimen : ( 1 ) CALa regimen : clarithromycin 500mg twice daily , amoxicillin 1000mg twice daily , lansoprazole 30mg twice daily 7 day , ( 2 ) LALa regimen : levofloxacin 750mg ( levofloxacin500 1.5 tablet ) daily , amoxicillin 1000mg twice daily , lansoprazole 30mg twice daily 7 day ( Figure 1 ) . Adverse event record throughout trial follow-up period . Patients return 13C-UBT 6 week completion treatment consider lost-to-follow-up exclude per protocol ( PP ) analysis . Rescue regimen treatment failure first-line regimen Patients remain positive H. pylorus initial treatment determine 13C-UBT followed endoscopy . Biopsy do H. pylori culture antibiotic susceptibility test . All treat rescue regimen . The rescue regimens give cross-over manner ( Figure 1 ) . Patients treat CALa regimen 7 day initial treatment treat LALa regimen 10 day rescue treatment . Patients treat LALa regimen 7 day initial treatment treat CALa regimen 10 day rescue treatment . Compliance Adverse Effect Patients ' compliance assess standardize interview end treatment well pill count medication box return interview . Compliance consider low 20 % pill find box . At enrollment , patient inform common side effect study antibiotic , include diarrhea , taste disturbance , nausea , bloating , loss appetite , vomit , abdominal pain , constipation , headache , skin rash .</detailed_description>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<criteria>Asymptomatic subject symptomatic patient H. pylori infection age great 20 year willing receive eradication therapy H. pylori Children teenager age less 20 year Previous eradication therapy H. pylori History gastrectomy Gastric malignancy , include adenocarcinoma lymphoma Previous allergic reaction antibiotic ( amoxicillin , clarithromycin , levofloxacin ) prompt pump inhibitor ( lansoprazole ) Use prompt pump inhibitor ( lansoprazole ) antibiotic ( amoxicillin , clarithromycin , levofloxacin ) recent 4 week Active upper GI bleeding recent 1 week Contraindication treatment drug Pregnant lactate woman Severe concurrent disease malignancy .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Helicobacter pylorus</keyword>
	<keyword>levofloxacin</keyword>
	<keyword>clarithromycin</keyword>
	<keyword>ERADICATION RATE</keyword>
</DOC>